Enhanced Group posts audited 2025 results, $25.3M cash, $26.7M loss and going concern noteTradingView·Aug 26 at 06:43 AMENHA+2.53%
Apeiron Investment Group reports acquisition of Enhanced Group common shares worth $2.92 millionPUBT·Aug 20 at 06:30 AMENHA+2.53%
Enhanced Announces Enhanced OS the AI Powered Operating System for Delivering Human Potential | ENHA Stock NewsStockTitan·Aug 17 at 10:30 PMENHA+2.53%
Apeiron Investment Group acquires Enhanced Group common shares valued at $295,620PUBT·Aug 17 at 05:11 AMENHA+2.53%
U.S. Stock Market Midday Update: Enhanced Group down 20%: Revenue misses expectations, transformation costs heavily impact stock pricePrice Alert·Aug 14 at 09:12 AMENHA+2.53%
Pre-market hot trades in US stocks: Enhanced Group pre-market down 7.6%: Q2 losses exceed expectations, telemedicine benefits fail to mask weak performancePrice Alert·Aug 14 at 07:43 AMENHA+2.53%
ENHA: Q2 revenue hit $17.7M, net loss $61.9M, with strong brand, global reach, and new product launchesQuartr·Aug 13 at 05:07 PMENHA+2.53%
Enhanced Q2 FY26 net loss widens to $61.9 million; revenue rises to $17.7 millionPUBT·Aug 13 at 03:07 PMENHA+2.53%ROKU+0.91%
Pre-market hot trades in US stocks: Up 7.84% before the market opens, no positive news? Active funds drive volatility, further observation neededPrice Alert·Aug 12 at 05:57 AMENHA+2.53%
Enhanced Group to report Q2 results after market close, host conference callPUBT·Aug 6 at 07:30 AMENHA+2.53%
Enhanced expands direct-to-consumer supplements to 33 markets outside USPUBT·Jul 30 at 06:48 AMENHA+2.53%
Enhanced Group applauds FDA panel vote backing peptide additions to 503A compounding listPUBT·Jul 27 at 06:31 AMENHA+2.53%
Enhanced Applauds FDA Advisory Committee's Landmark Vote to Expand Legal Compounding Pathway for Peptides | ENHA Stock NewsStockTitan·Jul 26 at 10:30 PMENHA+2.53%
12 Consumer Discretionary Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jul 17 at 12:05 PMVMAR+1.86%WKSP-8.73%
